Change in cardiac geometry and function in CKD children during strict BP control: A randomized study

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 2, 2013, Pages 203-210

  Matteucci, Maria Chiara ^a   Chinali, Marcello ^a   Rinelli, Gabriele ^a   Wühl, Elke ^b   Zurowska, Aleksandra ^c   Charbit, Marina ^d   Pongiglione, Giacomo ^a   Schaefer, Franz ^b  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CHILD; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE MONITORING, AMBULATORY; CHILD; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84875008051     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08420811     Document Type: Article

References (43)

1. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR: Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107: 864-868, 2003
2. Matteucci MC, Wühl E, Picca S, Mastrostefano A, Rinelli G, Romano C, Rizzoni G, Mehls O, de Simone G, Schaefer F; ESCAPE Trial Group;: Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 17: 218-226, 2006
3. Chinali M, de Simone G, Matteucci MC, Picca S, Mastrostefano A, Anarat A, Caliskan S, Jeck N, Neuhaus TJ, Peco-Antic A, Peruzzi L, Testa S, Mehls O, Wühl E, Schaefer F; ESCAPE Trial Group;: Reduced systolic myocardial function in children with chronic renal insufficiency. J Am Soc Nephrol 18: 593-598, 2007
4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the FraminghamHeart Study. NEngl J Med 322: 1561-1566, 1990
5. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114: 345-352, 1991
6. Liao Y, Cooper RS, McGee DL, MensahGA, Ghali JK: The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA 273: 1592-1597, 1995
7. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Reboldi G, Porcellati C: Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 97: 48-54, 1998
8. Yurenev AP, Dyakonova HG, Novikov ID, Vitols A, Pahl L, Haynemann G, Wallrabe D, Tsifkova R, Romanovska L, Niderle P: Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Multicenter trial. Am J Hypertens 5: 182S-189S, 1992
9. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E: Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 13: 1091-1095, 1995
10. Ulinski T, Genty J, Viau C, Tillous-Borde I, Deschênes G: Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr Nephrol 21: 1171-1178, 2006
11. Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF: Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol 16: 318-323, 2001
12. BorzychD, Zurowska A, Bałasz I, Sabiniewicz R, Erecinski J: [Left ventricular hypertrophy in paediatric predialysis children and treatment-induced regression of left ventricular mass]. Wiad Lek 58[Suppl 1]: 55-57, 2005
13. Ramaswamy P, Lytrivi ID, Paul C, Golden M, Kupferman JC: Regression of left ventricular hypertrophy in children with antihypertensive therapy. Pediatr Nephrol 22: 141-143, 2007
14. Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F: Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361: 1639-1650, 2009
15. Wühl E, Mehls O, Schaefer F; ESCAPE Trial Group;: Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66: 768-776, 2004
16. Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W: Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 130: 178-184, 1997
17. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F; German Working Group on Pediatric Hypertension: Distribution of 24-h ambulatory blood pressure in children: Normalized reference values and role of body dimensions. J Hypertens 20: 1995-2007, 2002
18. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography;: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463, 2005
19. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik AJ: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2: 358-367, 1989
20. de Simone G, Muiesan ML, Ganau A, Longhini C, Verdecchia P, Palmieri V, Agabiti-Rosei E, Mancia G; Reliability of M-mode Echocardiographic Studies;: Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. J Hypertens 17: 1955-1963, 1999
21. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH: Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20: 1251-1260, 1992
22. Khoury PR, Mitsnefes M, Daniels SR, Kimball TR: Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22: 709-714, 2009
23. de Simone G, Daniels SR, Kimball TR, Roman MJ, Romano C, Chinali M, Galderisi M, Devereux RB: Evaluation of concentric left ventricular geometry in humans: Evidence for age-related systematic underestimation. Hypertension 45: 64-68, 2005
24. Teichholz LE, Kreulen T, Herman MV, Gorlin R: Problems in echocardiographic volume determinations: Echocardiographicangiographic correlations in the presence of absence of asynergy. Am J Cardiol 37: 7-11, 1976
25. de Simone G, Devereux RB, Celentano A, Roman MJ: Left ventricular chamber and wall mechanics in the presence of concentric geometry. J Hypertens 17: 1001-1006, 1999
26. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, Laragh JH: Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 23: 1444-1451, 1994
27. Shimizu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch WH: Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation 83: 1676-1684, 1991
28. de Simone G, Kimball TR, Roman MJ, Daniels SR, Celentano A, Witt SA, Devereux RB: Relation of left ventricular chamber and midwall function to age in normal children, adolescents and adults. Ital Heart J 1: 295-300, 2000
29. Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 34: 571-590, 1987
30. Prader A, Largo RH, Molinari L, Issler C: Physical growth in Swiss children from birth to 20 years of age. Helv Paediatr Acta 52: S1-S125, 1989
31. Schaefer F, Georgi M, Wuhl E, Scharer K: Body mass index and percentage fat mass in healthy German schoolchildren and adolescents. Int J Obes Relat Metab Disord 22:461-469, 1998
32. Agabiti-Rosei E, Ambrosioni E, Dal Palù C, Muiesan ML, Zanchetti A: ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study on behalf of the RACE study group. J Hypertens 13: 1325-1334, 1995
33. Dahlöf B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 5: 95-110, 1992
34. Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH Jr, Neaton JD, Stamler J: Comparison of five antihypertensive monotherapies and placebo for change in left ventricularmass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 91: 698-706, 1995
35. Gosse P, Sheridan DJ, Zannad F, Dubourg O, Guéret P, Karpov Y, de Leeuw PW, Palma-Gamiz JL, Pessina A, Motz W, Degaute JP, Chastang C: Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: The LIVE study. J Hypertens 18: 1465-1475, 2000
36. Klingbeil AU, Schneider MP, Martus P, Messerli FH, Schmieder RE: A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 115: 41-46, 2003
37. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, Pessina A, Porcellati C, Rappelli A, Salvetti A, Trimarco B; SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation;: Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 95: 1464-1470, 1997
38. Roman MJ, Alderman MH, Pickering TG, Pini R, Keating JO, Sealey JE, Devereux RB: Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy. Am J Hypertens 11: 387-396, 1998
39. Devereux RB, Palmieri V, Liu JE, Wachtell K, Bella JN, Boman K, Gerdts E, NieminenMS, Papademetriou V, Dahlöf B: Progressive hypertrophy regression with sustained pressure reduction in hypertension: The Losartan Intervention For Endpoint Reduction study. J Hypertens 20: 1445-1450, 2002
40. Schlaich MP, Schmieder RE: Left ventricular hypertrophy and its regression: Pathophysiology and therapeutic approach: Focus on treatment by antihypertensive agents. Am J Hypertens 11: 1394-1404, 1998
41. Everett AD, Tufro-McReddie A, Fisher A, Gomez RA: Angiotensin inhibitors regressed cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension 23: 587-592, 1994
42. Pachori AS, Numan MT, Ferrario CM, Diz DM, Raizada MK, Katovich MJ: Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy. Hypertension 39: 969-975, 2002
43. Schaefer F, Mehls O: Hypertension in chronic kidney disease. In: Pediatric Hypertension, edited by Portman RJ, Sorof JM, Ingelfinger JR, Totowa, NJ, Humana Press, 2004, pp 371-387